{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T18:36:27Z","timestamp":1648838187883},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T00:00:00Z","timestamp":1542844800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13014-018-1174-z","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T04:40:53Z","timestamp":1542861653000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dosimetric comparison of different radiation techniques (IMRT vs. 3-dimensional) of the \u201ctrue\u201d (deep) ano-inguinal lymphatic drainage of anal cancer patients"],"prefix":"10.1186","volume":"13","author":[{"given":"Hendrik","family":"Dapper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Oechsner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Hirche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"M\u00fcnch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Borm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan C.","family":"Peeken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie E.","family":"Combs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Habermehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,22]]},"reference":[{"issue":"16","key":"1174_CR1","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","volume":"299","author":"JA Ajani","year":"2008","unstructured":"Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB, Thomas CR Jr, et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA. 2008;299(16):1914\u201321. \n                    https:\/\/doi.org\/10.1001\/jama.299.16.1914\n                    \n                  .","journal-title":"JAMA"},{"issue":"6","key":"1174_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","volume":"14","author":"RD James","year":"2013","unstructured":"James RD, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 x 2 factorial trial. Lancet Oncol. 2013;14(6):516\u201324. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(13)70086-X\n                    \n                  .","journal-title":"Lancet Oncol"},{"key":"1174_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/978-3-642-87383-6","volume-title":"Lymphographie und Tumordiagnostik","author":"WA Fuchs","year":"1965","unstructured":"Fuchs WA. Lymphographie und Tumordiagnostik. Berlin; Heidelberg; New York: Springer Verlag; 1965. p. 66."},{"key":"1174_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-28860-9","volume-title":"Target volume delineation and field setup: a practical guide for conformal and intensity modulated radiation therapy","author":"NY Lee","year":"2013","unstructured":"Lee NY, Lu JJ. Target volume delineation and field setup: a practical guide for conformal and intensity modulated radiation therapy. Berlin, Heidelberg: Springer; 2013."},{"issue":"3","key":"1174_CR5","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","volume":"74","author":"RJ Myerson","year":"2009","unstructured":"Myerson RJ, Garofalo MC, El Naqa I, Abrams RA, Apte A, Bosch WR, et al. Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys. 2009;74(3):824\u201330. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2008.08.070\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"1174_CR6","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1245\/s10434-010-1010-7","volume":"17","author":"C Hirche","year":"2010","unstructured":"Hirche C, Dresel S, Krempien R, H\u00fcnerbein M. Sentinel node biopsy by indocyanine green retention fluorescence detection for inguinal lymph node staging of anal cancer: preliminary experience. Ann Surg Oncol. 2010;17(9):2357\u201362. \n                    https:\/\/doi.org\/10.1245\/s10434-010-1010-7\n                    \n                  .","journal-title":"Ann Surg Oncol"},{"key":"1174_CR7","unstructured":"Doniga SG. Die Fluoreszenzfarbstoff-gest\u00fctzte Sentinel-Lymphknoten-Biopsie mittels Indocyanin Gr\u00fcn bei solit\u00e4ren Tumoren [@Berlin, Univ.-Medizin, Diss. 2013]. Verf\u00fcgbar unter: \n                    http:\/\/www.diss.fu-berlin.de\/diss\/receive\/FUDISS_thesis_000000094271\n                    \n                  ."},{"issue":"6","key":"1174_CR8","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1080\/0284186X.2017.1415459","volume":"57","author":"Hendrik Dapper","year":"2018","unstructured":"Dapper H, Habl G, Hirche C, M\u00fcnch S, Oechsner M, Mayinger M, et al. Dosimetric quantification of the incidental irradiation of the \u2018true\u2019 (deep) ano-inguinal lymphatic drainage of anal cancer patients not described in conventional contouring guidelines. Acta Oncol. 2018:1\u20136. \n                    https:\/\/doi.org\/10.1080\/0284186X.2017.1415459.","journal-title":"Acta Oncologica"},{"issue":"5","key":"1174_CR9","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.ijrobp.2011.02.010","volume":"82","author":"C Ortholan","year":"2012","unstructured":"Ortholan C, Resbeut M, Hannoun-Levi J-M, Teissier E, Gerard J-P, Ronchin P, et al. Anal canal cancer: management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 study). Int J Radiat Oncol Biol Phys. 2012;82(5):1988\u201395. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2011.02.010\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"1174_CR10","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/DCR.0000000000000050","volume":"57","author":"SE Blinde","year":"2014","unstructured":"Blinde SE, Schasfoort R, Mens JW, Verhoef C, Olofsen M, Nuyttens JJ. Inguinal lymph node recurrence in the untreated groin of patients with anal carcinoma. Dis Colon Rectum. 2014;57(5):578\u201384. \n                    https:\/\/doi.org\/10.1097\/DCR.0000000000000050\n                    \n                  .","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"1174_CR11","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ijrobp.2011.07.007","volume":"83","author":"JM Tomaszewski","year":"2012","unstructured":"Tomaszewski JM, Link E, Leong T, Heriot A, Vazquez M, Chander S, et al. Twenty-five-year experience with radical chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys. 2012;83(2):552\u20138. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2011.07.007\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1174_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ijrobp.2004.03.034","volume":"61","author":"PJ Nilsson","year":"2005","unstructured":"Nilsson PJ, Svensson C, Goldman S, Ljungqvist O, Glimelius B. Epidermoid anal cancer: a review of a population-based series of 308 consecutive patients treated according to prospective protocols. Int J Radiat Oncol Biol Phys. 2005;61(1):92\u2013102. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2004.03.034\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1174_CR13","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/bjs.1800720411","volume":"72","author":"RD James","year":"1985","unstructured":"James RD, Pointon RS, Martin S. Local radiotherapy in the management of squamous carcinoma of the anus. Br J Surg. 1985;72(4):282\u20135.","journal-title":"Br J Surg"},{"issue":"3","key":"1174_CR14","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.ijrobp.2006.12.052","volume":"68","author":"P Das","year":"2007","unstructured":"Das P, Bhatia S, Eng C, Ajani JA, Skibber JM, Rodriguez-Bigas MA, et al. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys. 2007;68(3):794\u2013800. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2006.12.052\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"1174_CR15","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3109\/0284186X.2015.1124141","volume":"55","author":"NB Tomasoa","year":"2016","unstructured":"Tomasoa NB, Meulendijks D, Nijkamp J, Cats A, Dewit L. Clinical outcome in patients treated with simultaneous integrated boost - intensity modulated radiation therapy (SIB-IMRT) with and without concurrent chemotherapy for squamous cell carcinoma of the anal canal. Acta Oncol. 2016;55(6):760\u20136. \n                    https:\/\/doi.org\/10.3109\/0284186X.2015.1124141\n                    \n                  .","journal-title":"Acta Oncol"},{"key":"1174_CR16","doi-asserted-by":"crossref","unstructured":"Bryant AK, Huynh-Le MP, Simpson DR, Murphy JD. Comparative effectiveness of IMRT and 3D comparative effectiveness of IMRT and 3D conformal radiation therapy for anal Cancer. Int J Radiat Oncol Biol Phys. 2017;99.","DOI":"10.1016\/j.ijrobp.2017.06.164"},{"issue":"1","key":"1174_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","volume":"86","author":"LA Kachnic","year":"2013","unstructured":"Kachnic LA, Winter K, Myerson RJ, Goodyear MD, Willins J, Esthappan J, et al. RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 2013;86(1):27\u201333. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2012.09.023\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1174_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.6004\/jnccn.2010.0008","volume":"8","author":"JM Pepek","year":"2010","unstructured":"Pepek JM, Willett CG, Czito BG. Radiation therapy advances for treatment of anal cancer. J Natl Compr Cancer Netw. 2010;8(1):123\u20139.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"5","key":"1174_CR19","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.ijrobp.2010.04.011","volume":"80","author":"AM Chen","year":"2011","unstructured":"Chen AM, Farwell DG, Luu Q, Chen LM, Vijayakumar S, Purdy JA. Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2011;80(5):1423\u20139. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2010.04.011\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1174_CR20","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ijrobp.2007.09.018","volume":"70","author":"DM Cannon","year":"2008","unstructured":"Cannon DM, Lee NY. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2008;70(3):660\u20135. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2007.09.018\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3 Suppl","key":"1174_CR21","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754.","volume":"76","author":"LB Marks","year":"2010","unstructured":"Marks LB, Yorke ED, Jackson A, ten Haken RK, Constine LS, Eisbruch A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S10\u20139. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2009.07.1754.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"1174_CR22","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.ijrobp.2011.12.058","volume":"83","author":"M Ng","year":"2012","unstructured":"Ng M, Leong T, Chander S, Chu J, Kneebone A, Carroll S, et al. Australasian gastrointestinal trials group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer. Int J Radiat Oncol Biol Phys. 2012;83(5):1455\u201362. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2011.12.058\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1174_CR23","unstructured":"R Muirhead, RA Adams, DC Gilbert, M Harrison, R Glynne-Jones, D Sebag-Montefiore, MA Hawkins. National guidance for IMRT in anal national guidance for IMRT in anal cancer: the CRUK\/MRC Oxford Institute for Radiation Oncology, Oxford, UK; School of Medicine, Cardiff University, Cardiff, UK; Sussex Cancer Centre, Royal Sussex County Hospital, Brighton, UK; Mount Vernon Hospital, Northwood, UK; University of Leeds, St James Institute of Oncology, Leeds, UK; 2016 [Stand: 08.08.2018]. Verf\u00fcgbar unter: \n                    http:\/\/analimrtguidance.co.uk\/national-anal-imrt-guidance-v3.pdf\n                    \n                  ."},{"key":"1174_CR24","volume-title":"Duale Reihe - Anatomie. Duale Reihe 1. Aufl","author":"G Aum\u00fcller","year":"2007","unstructured":"Aum\u00fcller G, Wolff W. Duale Reihe - Anatomie. Duale Reihe 1. Aufl. Stuttgart: Thieme; 2007. Duale Reihe"},{"issue":"3","key":"1174_CR25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3978\/j.issn.2078-6891.2014.026.","volume":"5","author":"ED Scher","year":"2014","unstructured":"Scher ED, Ahmed I, Yue NJ, Jabbour SK. Technical aspects of radiation therapy for anal cancer. J Gastrointest Oncol. 2014;5(3):198\u2013211. \n                    https:\/\/doi.org\/10.3978\/j.issn.2078-6891.2014.026.","journal-title":"J Gastrointest Oncol"},{"issue":"5","key":"1174_CR26","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/COC.0b013e31827e52a3","volume":"37","author":"MP Mitchell","year":"2014","unstructured":"Mitchell MP, Abboud M, Eng C, Beddar AS, Krishnan S, Delclos ME, et al. Intensity-modulated radiation therapy with concurrent chemotherapy for anal cancer: outcomes and toxicity. Am J Clin Oncol. 2014;37(5):461\u20136. \n                    https:\/\/doi.org\/10.1097\/COC.0b013e31827e52a3\n                    \n                  .","journal-title":"Am J Clin Oncol"},{"issue":"9","key":"1174_CR27","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1038\/bjc.2014.467","volume":"111","author":"D Meulendijks","year":"2014","unstructured":"Meulendijks D, Dewit L, Tomasoa NB, van Tinteren H, Beijnen JH, Schellens JHM, et al. Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option. Br J Cancer. 2014;111(9):1726\u201333. \n                    https:\/\/doi.org\/10.1038\/bjc.2014.467\n                    \n                  .","journal-title":"Br J Cancer"},{"key":"1174_CR28","doi-asserted-by":"crossref","unstructured":"Koeck J, Lohr F, Buergy D, B\u00fcsing K, Trunk MJ, Wenz F, Mai S. Genital invasion or perigenital spread may pose a risk of marginal misses for Intensity Modulated Radiotherapy (IMRT) in anal cancer: BioMed Central Ltd; 2016.","DOI":"10.1186\/s13014-016-0628-4"},{"issue":"4","key":"1174_CR29","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.ijrobp.2009.09.029","volume":"78","author":"JL Wright","year":"2010","unstructured":"Wright JL, Patil SM, Temple LKF, Minsky BD, Saltz LB, Goodman KA. Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning. Int J Radiat Oncol Biol Phys. 2010;78(4):1064\u201372. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2009.09.029\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1174-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-018-1174-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1174-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T19:09:44Z","timestamp":1574363384000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-018-1174-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,22]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1174"],"URL":"https:\/\/doi.org\/10.1186\/s13014-018-1174-z","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,22]]},"assertion":[{"value":"18 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in accordance with the ethics standards at the Techniqueal University of Munich (TUM) (ethical vote: 28.02.2018s, 88\/18\u2009S).Name of committee: Ethikkommission der Technischen Universit\u00e4t M\u00fcnchen.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"227"}}